WallStreetZenWallStreetZen

NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock Ownership - Who owns Teva Pharmaceutical Industries?

Buy TEVA
OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Teva Pharmaceutical Industries Ltd insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
David Matthew StarkExec. VP Chief Legal Officer2022-07-2858,163$9.04
$525.62kSell
Hafrun FridriksdottirExecutive VP Global R&D2022-05-17130,000$8.22
$1.07MSell
David Matthew StarkExec. VP Chief Legal Officer2022-03-079,057$7.37
$66.72kSell
Eric DrapeExecutive VP Global Operations2022-03-0711,334$7.37
$83.50kSell
Richard DaniellExec. VP European Commercial2022-03-0722,576$7.37
$166.32kSell
Hafrun FridriksdottirExecutive VP Global R&D2022-03-078,941$7.37
$65.87kSell
Sven DethlefsEVP North America Commercial2022-03-076,993$7.37
$51.52kSell
Eric DrapeExecutive VP Global Operations2022-03-0417,157$7.48
$128.37kSell
David Matthew StarkExec. VP Chief Legal Officer2022-03-0417,008$7.48
$127.25kSell
David Matthew StarkExec. VP Chief Legal Officer2022-03-046,246$7.48
$46.73kSell

1 of 3

TEVA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

TEVA Shareholders

What type of owners hold Teva Pharmaceutical Industries Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Capital Research Global Investors8.39%93,166,283$1.04BInstitution
Blackrock Inc3.88%43,077,603$482.47MInstitution
Abrams Capital Management LP2.17%24,046,356$269.32MInstitution
Menora Mivtachim Holdings Ltd2.10%23,310,610$261.08MInstitution
Migdal Insurance Financial Holdings Ltd1.76%19,532,920$218.77MInstitution
Clal Insurance Enterprises Holdings Ltd1.71%18,962,766$212.38MInstitution
Phoenix Holdings Ltd1.67%18,529,789$207.53MInstitution
State Street Corp1.25%13,846,013$155.08MInstitution
Harel Insurance Investments Financial Services Ltd1.03%11,447,527$128.21MInstitution
Capital International Investors0.96%10,682,878$119.65MInstitution

1 of 3

TEVA vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TEVA44.85%0.75%Net SellingNet Selling
VTRS72.29%17.41%Net SellingNet Selling
ELAN90.51%9.49%Net SellingNet Buying
RDY9.36%0.00%
PRGO61.42%38.58%Net Buying
View Top Pharmaceutical Stocks

Teva Pharmaceutical Industries Stock Ownership FAQ

Who owns Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries (NYSE: TEVA) is owned by 44.85% institutional shareholders, 0.75% Teva Pharmaceutical Industries insiders, and 54.40% retail investors. Capital Research Global Investors is the largest individual Teva Pharmaceutical Industries shareholder, owning 93.17M shares representing 8.39% of the company. Capital Research Global Investors's Teva Pharmaceutical Industries shares are currently valued at $1.03B.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.